Deterministic, branch-selective optimization of peptidomimetic scaffolds reveals design principles for targeting
Hao Chen1, Lilin Song1, Yushuang Dai1
1National Key Laboratory of Immunity and Inflammation, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences & Peking Union Medical College, Suzhou, Jiangsu, 215123, China.
Abstract:
Tumor necrosis factor-α (TNF-α) is a central driver of chronic inflammatory diseases, yet the development of non-biologic TNF-α inhibitors remains challenging due to the large, shallow nature of its protein-protein interface. Peptides offer a promising alternative to small molecules; however, rational optimization of complex peptide architectures such as branched or cyclic scaffolds remains a major bottleneck, as conventional approaches often rely on empirical screening or low-resolution mutagenesis. Here, we report a deterministic, branch-selective optimization strategy for a lysine-centered branched peptidomimetic TNF-α inhibitor using On-Demand Array Synthesis and Screening (ODAST). Through three iterative rounds of hypothesis-driven diversification, we systematically resolved the roles of charge identity, charge density, and cooperative aromatic interactions across distinct branches of the scaffold. This process led to the identification of a conserved bidentate anionic recognition motif, paired with aromatic and hydrogen-bonding elements that cooperatively stabilize TNF-α binding. The optimized peptides exhibited >10-fold improvements in apparent affinity and effectively inhibited TNF-α-induced cytotoxicity, with a lead compound displaying low-micromolar cellular IC50 values. Collectively, this work establishes a generalizable framework for rationally optimizing multivalent peptide architectures against challenging protein surfaces and provides design principles applicable beyond TNF-α to other cytokines and protein-protein interaction targets.
More Related Videos
Related Concept Videos
TGF - β Signaling Pathway
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase


